Zobrazeno 1 - 8
of 8
pro vyhledávání: '"William-Henry Bolland"'
Autor:
Delphine Planas, Isabelle Staropoli, Vincent Michel, Frederic Lemoine, Flora Donati, Matthieu Prot, Francoise Porrot, Florence Guivel-Benhassine, Banujaa Jeyarajah, Angela Brisebarre, Océane Dehan, Léa Avon, William Henry Bolland, Mathieu Hubert, Julian Buchrieser, Thibault Vanhoucke, Pierre Rosenbaum, David Veyer, Hélène Péré, Bruno Lina, Sophie Trouillet-Assant, Laurent Hocqueloux, Thierry Prazuck, Etienne Simon-Loriere, Olivier Schwartz
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.5.1.1, EG.5.1.3, XBF, BA.2.86.1 and JN.1 variants, representing
Externí odkaz:
https://doaj.org/article/8234f50bbc5043a1a52a4adceb8cfad0
Autor:
Timothée Bruel, Karl Stéfic, Yann Nguyen, Donatella Toniutti, Isabelle Staropoli, Françoise Porrot, Florence Guivel-Benhassine, William-Henry Bolland, Delphine Planas, Jérôme Hadjadj, Lynda Handala, Cyril Planchais, Matthieu Prot, Etienne Simon-Lorière, Emmanuel André, Guy Baele, Lize Cuypers, Luc Mouthon, Hugo Mouquet, Julian Buchrieser, Aymeric Sève, Thierry Prazuck, Piet Maes, Benjamin Terrier, Laurent Hocqueloux, Olivier Schwartz
Publikováno v:
Cell Reports Medicine
Cell Reports Medicine, 2022, 3 (12), pp.100850. ⟨10.1016/j.xcrm.2022.100850⟩
Cell Reports Medicine, 2022, 3 (12), pp.100850. ⟨10.1016/j.xcrm.2022.100850⟩
The emergence of novel Omicron lineages, such as BA.5, may impact the therapeutic efficacy of anti-SARS-CoV-2 neutralizing monoclonal antibodies (mAbs). Here, we evaluated the neutralization and ADCC activity of 6 therapeutic mAbs against Delta, BA.2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cecd71525cf43285d6886410bcbf921
https://lirias.kuleuven.be/handle/20.500.12942/710723
https://lirias.kuleuven.be/handle/20.500.12942/710723
Autor:
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, Benjamin Terrier, Thierry Prazuck, Olivier Schwartz
Publikováno v:
Nature Medicine
Nature Medicine, 2022, ⟨10.1038/s41591-022-01792-5⟩
Nature Medicine, Nature Publishing Group, 2022, ⟨10.1038/s41591-022-01792-5⟩
Nature Medicine, 2022, ⟨10.1038/s41591-022-01792-5⟩
Nature Medicine, Nature Publishing Group, 2022, ⟨10.1038/s41591-022-01792-5⟩
International audience; The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 mutations in its spike. In this study, we first compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7eb5c8cc46eef2367733b71b06ae7b
https://hal-pasteur.archives-ouvertes.fr/pasteur-03654237
https://hal-pasteur.archives-ouvertes.fr/pasteur-03654237
Autor:
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, Benjamin Terrier, Thierry Prazuck, Olivier Schwartz
The SARS-CoV-2 Omicron BA.1 variant has been supplanted in many countries by the BA.2 sub-lineage. BA.2 differs from BA.1 by about 21 mutations in its spike. Human anti-spike monoclonal antibodies (mAbs) are used for prevention or treatment of COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd830c54b80b794dfde60399391145fa
https://doi.org/10.1101/2022.03.09.22272066
https://doi.org/10.1101/2022.03.09.22272066
Autor:
Delphine Planas, Nell Saunders, Piet Maes, Florence Guivel-Benhassine, Cyril Planchais, Julian Buchrieser, William-Henry Bolland, Françoise Porrot, Isabelle Staropoli, Frederic Lemoine, Hélène Péré, David Veyer, Julien Puech, Julien Rodary, Guy Baele, Simon Dellicour, Joren Raymenants, Sarah Gorissen, Caspar Geenen, Bert Vanmechelen, Tony Wawina-Bokalanga, Joan Martí-Carreras, Lize Cuypers, Aymeric Sève, Laurent Hocqueloux, Thierry Prazuck, Félix A. Rey, Etienne Simon-Loriere, Timothée Bruel, Hugo Mouquet, Emmanuel André, Olivier Schwartz
Publikováno v:
Nature
Nature, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, Nature Publishing Group, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, Nature Publishing Group, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1-3. It has since spread to many countries and is expected to rapidly become dominant worldwide. The lineage is characterized by the presence of around 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f32775e696f14e344c61284cb0faa4f
https://doi.org/10.1038/d41586-021-03827-2
https://doi.org/10.1038/d41586-021-03827-2
Autor:
Delphine Planas, Nell Saunders, Piet Maes, Florence Guivel-Benhassine, Cyril Planchais, Julian Buchrieser, William-Henry Bolland, Françoise Porrot, Isabelle Staropoli, Frederic Lemoine, Hélène Péré, David Veyer, Julien Puech, Julien Rodary, Guy Baela, Simon Dellicour, Joren Raymenants, Sarah Gorissen, Caspar Geenen, Bert Vanmechelen, Tony Wawina-Bokalanga, Joan Martí-Carrerasi, Lize Cuypers, Aymeric Sève, Laurent Hocqueloux, Thierry Prazuck, Félix Rey, Etienne Simon-Lorrière, Timothée Bruel, Hugo Mouquet, Emmanuel André, Olivier Schwartz
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1,2. It has in the meantime spread to many countries and is expected to rapidly become dominant worldwide. The lineage is characterized by the presence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa80faad3e7fe86b6087271ec09476d
https://doi.org/10.1101/2021.12.14.472630
https://doi.org/10.1101/2021.12.14.472630
Autor:
Delphine Planas, Isabelle Staropoli, Françoise Porot, Florence Guivel-Benhassine, Lynda Handala, Mathieu Prot, William-Henry Bolland, Julien Puech, Hélène Péré, David Veyer, Aymeric Sève, null Etienne-Simon-Lorière, Timothée Bruel, Thierry Prazuck, Karl Stefic, Laurent Hocqueloux, Olivier Schwartz
Publikováno v:
Med
Med, 2022, 3 (12), pp.838-847.e3. ⟨10.1016/j.medj.2022.09.010⟩
Med, 2022, 3 (12), pp.838-847.e3. ⟨10.1016/j.medj.2022.09.010⟩
Since early 2022, Omicron BA.1 has been eclipsed by BA.2, which was in turn outcompeted by BA.5, which displays enhanced antibody escape properties.Here, we evaluated the duration of the neutralizing antibody (Nab) response, up to 18 months after Pfi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cfebfb3d10d0a62e681fe37631ae09d
https://doi.org/10.1016/j.medj.2022.09.010
https://doi.org/10.1016/j.medj.2022.09.010
Autor:
Idris Boudhabhay, Alexandra Serris, Aude Servais, Delphine Planas, Aurélie Hummel, Bruno Guery, Perrine Parize, Claire Aguilar, Myriam Dao, Claire Rouzaud, Elsa Ferriere, Bertrand Knebelmann, Hamza Sakhi, Marianne Leruez, Dominique Joly, Olivier Schwartz, Fanny Lanternier, Timothée Bruel
Publikováno v:
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press, 2022, pp.gfac016. ⟨10.1093/ndt/gfac016⟩
Nephrology Dialysis Transplantation, 2022, pp.gfac016. ⟨10.1093/ndt/gfac016⟩
Nephrology Dialysis Transplantation, Oxford University Press, 2022, pp.gfac016. ⟨10.1093/ndt/gfac016⟩
Nephrology Dialysis Transplantation, 2022, pp.gfac016. ⟨10.1093/ndt/gfac016⟩
Background Patients on maintenance haemodialysis (HD) have an increased risk of severe coronavirus disease 2019 (COVID-19) and a reduced response to vaccines. Data are needed to identify immune correlates of protection in this population. Methods Fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20415dea43e2f1e88223b1b59501192
https://pubmed.ncbi.nlm.nih.gov/35104884
https://pubmed.ncbi.nlm.nih.gov/35104884